College of Veterinary Medicine / University of Mosul
  • Register
  • Login
  • العربیة

Iraqi Journal of Veterinary Sciences

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 36, Issue 3
  3. Authors

Current Issue

By Issue

By Subject

Keyword Index

Author Index

Indexing Databases XML

About Journal

Aims and Scope

Editorial Board

Editorial Staff

Facts and Figures

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

News

The beneficial effects of resveratrol supplementation on parasitemia, oxidative stress and serum biochemical parameters in Trypanosoma brucei infected dogs

    Chigozie S Ukwueze Polycarp O Akpa Rita I Odo Chinwe J Aronu Boniface M Anene

Iraqi Journal of Veterinary Sciences, 2022, Volume 36, Issue 3, Pages 753-760
10.33899/ijvs.2022.131843.2009

  • Show Article
  • Full Text
  • References
  • Download
  • Cite
  • Statistics
  • Share

Abstract

This study investigated the effect of resveratrol supplementation on parasitemia, oxidative stress and serum biochemical changes in the Trypanosoma brucei infected dogs. The mean pre-patent period (MPP) of infection was 5.75±0.96 (5-7) days and 9.00 ± 0.82 (8-10) days between infected un-supplemented and supplemented respectively, which differed significantly (p<0.05). There was a significant increase (P<0.05) in the activities of malondialdehyde (MDA) post infection (pi) on the infected untreated group compared with the infected treated groups and the control. The mean serum alanine aminotransaminase (ALT) and aspartate aminotransferase (AST) were significantly (P>0.05) higher than the infected treated groups. The mean ALT of infected treated with both resveratrol and diminazene aceturate (DA) was significantly (P<0.05) lower than other infected treated groups. The mean creatinine and blood urea nitrogen (BUN) levels were significantly (P<0.05) higher in the infected untreated group. The creatinine level of the infected treated with both resveratrol and DA was significantly (P<0.05) lower than other infected treated groups, whereas the BUN did not differ significantly (P>0.05) within the infected treated groups when compared with the control. The mean albumin and total protein were significantly (P<0.05) higher in the infected untreated group, but the infected treated groups did not show any significant (P>0.05) difference. However, the total protein was significantly (P<0.05) higher in the infected treated with resveratrol than in other infected groups. It was concluded that pretreatment with resveratrol is beneficial in managing T. brucei infection, as it delays the onset of parasitemia and restores damages done to the liver and kidneys when combined with diminazene aceturate. 
Keywords:
    Resveratrol supplementation Trypanosoma brucei Parasitemia Oxidative stress
Main Subjects:
  • Pet Animals

The beneficial effects of resveratrol supplementation on parasitemia, oxidative stress and serum biochemical parameters in Trypanosoma brucei infected dogs

 

Akpa P. O.,1 Ukwueze C. S*2, Odo R. I3, Aronu C. J.,4 Anene B. M1

 

1Department of Veterinary Medicine, University of Nigeria, Nsukka, 2Department of Veterinary Medicine, Michael Okpara University of Agriculture, Umudike, 3Department of Veterinary Physiology and Pharmacology, University of Nigeria, 4Department of Animal Health and Production, University of Nigeria, Nsukka, Nigeria

 

ukwueze.chigozie@mouau.edu.ng

 

Abstract

 

This study investigated the effect of resveratrol supplementation on parasitemia, oxidative stress and serum biochemical changes in the Trypanosoma brucei infected dogs. The mean pre-patent period (MPP) of infection was 5.75±0.96 (5-7) days and 9.00 ± 0.82 (8-10) days between infected un-supplemented and supplemented respectively, which differed significantly (p<0.05). There was a significant increase (P<0.05) in the activities of malondialdehyde (MDA) post infection (pi) on the infected untreated group compared with the infected treated groups and the control. The mean serum alanine aminotransaminase (ALT) and aspartate aminotransferase (AST) were significantly (P>0.05) higher than the infected treated groups. The mean ALT of infected treated with both resveratrol and diminazene aceturate (DA) was significantly (P<0.05) lower than other infected treated groups. The mean creatinine and blood urea nitrogen (BUN) levels were significantly (P<0.05) higher in the infected untreated group. The creatinine level of the infected treated with both resveratrol and DA was significantly (P<0.05) lower than other infected treated groups, whereas the BUN did not differ significantly (P>0.05) within the infected treated groups when compared with the control. The mean albumin and total protein were significantly (P<0.05) higher in the infected untreated group, but the infected treated groups did not show any significant (P>0.05) difference. However, the total protein was significantly (P<0.05) higher in the infected treated with resveratrol than in other infected groups. It was concluded that pretreatment with resveratrol is beneficial in managing T. brucei infection, as it delays the onset of parasitemia and restores damages done to the liver and kidneys when combined with diminazene aceturate.

 

Keywords: Resveratrol, Supplementation, Trypanosoma brucei, Parasitemia, Oxidative stress.

 

Introduction

 

African animal trypanosomosis is a debilitating disease of humans and animals, often caused by T. brucei, and T. congolense in dogs (1,2). The disease is widespread and essential in Africa and sub-saharan African countries and affects a wide range of animals (3,4), leading to massive impact on economic losses, not only in dogs but in other animals as well, manifested as mortalities, reduced meat and milk yield in food animals and cost of treatment (5). Oxidative stress and inflammatory reactions have been suggested to play significant roles in the pathogenesis of trypanosomosis (6,7). Free radicals and many peroxides generated by trypanosomes and activated by mononuclear phagocytes predispose cells to early aging, organ damage and death (8,9). Current trypanosomosis treatment and control strategies pose many challenges, because they depend on chemotherapy (9). The chemotherapy of trypanosomosis is characterized by drug toxicity, parasite resistance, and the parasite’s ability to survive in cryptic areas poorly accessible to drugs, especially the brain (10,11). The absence of new curative drugs has further complicated the situation. The drugs have been combined with other therapeutic agents to ensure the optimal therapeutic performance of the available trypanocides and reduce toxicity (12-14). Several workers have reported using of antioxidants to enhance the efficacy of diminazene aceturate (15,16), though the result of antioxidants alone is gratifying, but not effective in eliminating the parasite (14). Resveratrol has been demonstrated as a potent and powerful antioxidant associated with antiaging, anticancer, anti-inflammatory effects and slows down a wide variety of illnesses (17,18). Recent studies have shown the quest, for searching a better way of managing trypanosomosis in animals and reduce the toxicity caused by the commonly used trypanocides.

Therefore, this work was designed to access the ameliorative effects of combination therapy of resveratrol supplementation and diminazene aceturate on oxidative stress and organ damage in T. brucei infected dogs.

 

Materials and methods

 

Experimental Animals

A total of twenty male dogs between the ages of 6 and 12 months were used for the study. The dogs were purchased from the Orba market in Enugu State, Nigeria. On arrival at the animal house, they were allowed to acclimatize before the commencement of the experiment. The blood and fecal samples were collected and examined for the presence of haemo and gastrointestinal-parasites. Animal studies complied with the ethical procedure of the Animal Use and Care Committee, College of Veterinary Medicine, Michael Okpara University of Agriculture, Umudike, which corresponds with NIH guidelines (19).

 

Experimental procedure

The dogs were acclimatized for two weeks before the commencement of the study, and the animals were grouped into five of four dogs each. Dogs in group I (Control) were uninfected and un-supplemented with resveratrol. Group II was infected, un-supplemented, and untreated. While groups III, IV and V were infected, un-supplemented with diminazene aceturate (DA) treated, infected with resveratrol-supplemented, and untreated with diminazene aceturate (DA), and infected with resveratrol-supplemented, and diminazene aceturate (DA) treated respectively.

 

Resveratrol and Diminazene aceturate administration

Ninety-nine percent pure resveratrol powder (Candlewood Star Incorporated Danbury, Connecticut, USA) was for the study. Due to its low solubility in water, trans-resveratrol was suspended in 10 g/L of carboxymethylcellulose (CMC) and administered orally at 100mg/kg body weight. Groups IV and V were pre-treated with resveratrol seven days before infection and fourteen days post-infection. Groups III and V were treated on day ten post infection (PI) (peak parasitemia) with diminazene aceturate at 7mg/kg body weight. The control group received ten g/L of (CMC) orally.

 

Trypanosome infection

T. brucei were obtained from the Department of Parasitology and Entomology, University of Nigeria, Nsukka. The trypanosome was first inoculated into a donor dog, before being used for infection of the experimental animals intraperitoneally (ip) at a dose of 1.5 × 106 trypanosomes per milliliter of saline diluted blood. The number of infective trypanosomes was determined using the rapid matching method of Herbert and Lumsden (20). Parasitemia was monitored in each infected dog daily from day two to patency.

 

Blood collection

About 5mls of blood was collected from each dog to monitor parasitemia, serum biochemical analysis and oxidative stress markers. The blood was put into a clean EDTA bottle, for parasitemia monitoring. The remaining 4mls of blood was put into a clean dry glass for serum biochemistry analysis and oxidative stress markers. These tubes were allowed to stay for some time to enhance serum yield and was later centrifuged at 2000rpm for 10 min to separate the sera from the cells.

Malondialdehyde (MDA) was determined according to Fauziah et al. (21). Catalase (CAT) activity was determined according to Iwase et al. (22). Reduced glutathione (GSH) was estimated as described by Hamid et al. (23). Serum superoxide dismutase (SOD) activity was measured according to Gaeta et al. (24). While, total serum protein, albumin, urea, creatinine, alanine aminotransaminase (ALT), aspartate aminotransferase (AST) and alkaline phosphatase (ALP) were determined using commercial kits (Randox) according to the manufacturer’s instruction.

 

Statistical analysis

Data obtained from the study were analyzed using the one-way analysis of variance (ANOVA), and variant means separated by Duncan’s multiple range tests, in SPSS version 20. A Significant difference was accepted at a probability level of p≤0.05.

 

Results

 

The mean pre-patent period (MPP) of infection was 5.75 ± 0.96 (5-7) days and 9.00 ± 0.82 (8-10) days between infected un-supplemented and supplemented respectively, which differed significantly (P<0.05). The level of parasitemia was significantly different (P<0.05) between supplemented and un-supplemented infected groups on days 9 and 10 (Table 1). There was a significant increase (P<0.05) in the activities of MDA pi on the infected untreated group compared with the infected treated groups and the control. The MDA of the resveratrol and DA treated group was significantly (P<0.05) lower than other infected treated groups when compared with the control (Figure 1). Then mean serum reduced glutathione (GSH), superoxide dismutase (SOD), and CAT activities were significantly (P<0.05) lower in the infected untreated group comparable with the control. In contrast, the activities were significantly (P<0.05) higher in the resveratrol and DA treated group than other infected treated groups (Figures 2-4). However, the mean GSH and SOD were significantly (P<0.05) higher in the DA treated group than the resveratrol treated group. The mean CAT activities did not differ significantly (P>0.05) between the DA and resveratrol treated groups. The mean ALT and AST were significantly (P>0.05) higher than the infected treated groups. The mean ALT infected treated with both resveratrol and DA was significantly (P<0.05) lower than other infected treated groups (Figures 5, 6). The mean AST did not show any significant (P>0.05) difference in the infected treated groups. The mean ASP of infected untreated and DA groups were significantly (P<0.05) higher than the other infected treated group, however the resveratrol and DA treated group was significantly (P<0.05) lower than the resveratrol treated group and comparable with the control (Figure 7). The mean creatinine and BUN levels were significantly (P<0.05) higher in the infected untreated group. The creatinine level of the infected treated with both resveratrol and DA was significantly (P<0.05) lower than other infected treated groups, whereas the BUN did not differ significantly (P>0.05) within the infected treated groups when compared with the control (Figures 8 and 9). The mean albumin and total protein were significantly (P<0.05) higher in the infected untreated group, but the infected treated groups did not show any significant (P>0.05) difference However, the total protein was significantly (P<0.05) higher in the infected treated with resveratrol than in other infected groups (Figures 10 and 11).

 

Table 1: Mean (±SE) parasitemia (log10 trypanosomes/ml) of resveratrol supplemented T. brucei infected dogs treated with DA

 

Days post infection

Groups

Untreated

DA treated

Resveratrol treated

Resveratrol + DA treated

5

7.05±0.87

7.20±0.21

 

 

6

7.65±0.20

7.50±0.17

 

 

7

7.80±0.12

7.80±0.12

 

 

8

7.86±0.14

7.80±0.12

7.20±0.12

7.20±0.12

9

8.03±0.14*

8.08±0.75*

7.65±0.87**

7.56±0.75**

10

8.40±0.12*

8.40±0.17*

7.9±0.75**

7.9±0.14**

Means ±SEM marked * is significantly different from mean marked **

 

 

 

Figure 1: The mean Malondialdehyde (MDA) (n mol/ml) of resveratrol supplemented T. brucei infected dogs treated with DA.

 

 

 

Figure 2: The mean serum reduced glutathione (GSH) (n mol/ml) of resveratrol supplemented T. brucei infected dogs treated with DA.

 

 

 

Figure 3: The mean serum superoxide dismutase (SOD) (U/ml) of resveratrol supplemented T. brucei infected dogs treated with DA.

 

 

 

Figure 4: The Mean serum catalase (CAT) (KU/L) of resveratrol supplemented T. brucei infected dogs treated with DA.

 

 

 

 

 

 

 

 

Figure 5: The Mean serum alanine aminotransaminase (ALT) (IU/L) of resveratrol supplemented T. brucei infected dogs treated with DA.

 

 

 

Figure 6: The Mean serum aspartate aminotransferase (AST) (IU/L) of resveratrol supplemented T. brucei infected dogs treated with DA.

 

 

 

Figure 7: The Mean serum alkaline phosphatase (AP) (IU/L) of resveratrol supplemented T. brucei infected dogs treated with DA.

 

 

 

Figure 8: The Mean serum creatinine (mg/dl) of resveratrol supplemented T. brucei infected dogs treated with DA.

 

 

 

Figure 9: The Mean serum blood urea nitrogen (mg/dl) of resveratrol supplemented T. brucei infected dogs treated with DA.

 

 

 

Figure 10: The Mean serum albumin (g/dl) of resveratrol supplemented T. brucei infected dogs treated with DA.

 

 

 

Figure 11: The Mean serum total protein (g/dl) of resveratrol supplemented T. brucei infected dogs treated with DA.

 

Discussion

 

Several studies have continued to report the promising effects of antioxidants supplementation in combating the scourge of African animal trypanosomosis (15,14), though antioxidants alone are ineffective in eliminating the trypanosome parasites from the blood of an infected animal (14). In this study, the parasitemia was first observed in the unsupplemented infected group with a mean pre-patent period of 5.75±0.96 in 5-7 days and increased progressively in the untreated group until deaths of the animals. The supplemented infected group had more extended pre-patent period of 9.00±0.82 in 8-10 days. The result shows that antioxidants delayed the onset of parasitemia in the supplemented groups. This result agrees with previous workers Eze and Ochike (15) and Eze et al. (16), who stated that antioxidants supplementation suppresses the occurrence of parasitema in infected animals. The findings could also be attributed to the immunomodulatory and antioxidants effects of resveratrol (25,26), which minimized the physiological stress, enhancing the immune response and antioxidant status of the infected animal (27). The significantly increased (MDA) observed in the infected untreated group indicates African animal trypanosomosis is associated with oxidative stress (28,15,29,30). The increase in the mean MDA is attributable to elicited increased production of pro-oxidants reported in trypanosomosis (31). The enhanced antioxidant GSH, SOD and CAT activities observed in the resveratrol and DA treated groups show that resveratrol is a powerful antioxidant and immune modulator (17,18). Immunosuppression is a significant manifestation of infection with trypanosome parasites (16). Several workers have reported increased MDA and decrease antioxidants markers in African trypanosomosis (16,32-34). The estimation activities of antioxidant markers are indirect ways to access the status of antioxidant defense in the body (34). Also, the decrease in the antioxidant activities post-infection could be attributed to the fact that infection with T. brucei leads to systemic depletion of antioxidants and decreased liver carotenoid concentration (31).

Infection caused a significantly increased mean serum ALT AST and ALP in the infected unsupplemented animals. Similar results have also been reported by previous workers Umar et al. (28), Takeet and Fagbemi (36), Yusuf et al. (37), and Hussain et al. (38), and are indicative of liver, heart and brain damage associated with trypanosomosis. The mean serum creatinine was significantly lower in the DA treated and both resveratrol and DA treated groups when compared with the control. The result agrees with Awobode’s (39) findings, who reported significantly higher plasma creatinine levels in the T. gambiense infected population than in their uninfected control group. Abenga and Anosa (40) also observed a similar result in vervet monkeys infected with T. gambiense. An elevated mean serum BUN was observed in the untreated, suggesting renal pathology. This result corroborates Abenga et al. (41), who observed an increased BUN in pigs infected with T. brucei. Similarly, elevated BUN levels by 50% have also been observed in red Sokoto goats infected with T. vivax (41).

A significantly higher mean total serum protein and albumin were observed in the infected untreated. The result agrees with the previous works of Abenga et al. (41), who observed elevated total protein in pigs infected with T. vivax. Similar results have been observed in humans, goats, rabbits, and monkeys infected with T. rhodesiense (41), T. brucei (42,43), respectively, and pigs infected with T. brucei (45). An increase total protein in African trypanosomosis is mainly due to hyperglobulinaemia and hypergammaglobulinaemia. It has also been associated with increased immunoglobulin M and dehydration, which is a consistent finding in trypanosomosis of man and animals (45). The hypoalbuminaemia was observed in the infected untreated, contrary to the results of other workers, Adejinmi andAkinboade (42), Sivajothi et al. (45), and Abenga and Anosa (40), who reported elevated albumin levels in trypanosome infected animals. However, variations in serum biochemical changes in trypanosomosis have been reported and are associated with different infecting species of trypanosomes and animal hosts (45).

From the results of this study, pretreatment with resveratrol before giving DA showed a protective effect against oxidative stress and reversed the damages done by the infection to the liver and kidneys. The superiority of resveratrol and DA combination over resveratrol and DA is mainly due to the protective and antioxidants effects of resveratrol leading to enhanced immune response (25, 26). Several authors have reported the beneficial effects of antioxidants and micronutrients in trypanosomosis management. Improving host nutrition, through supplementation of antioxidants and micronutrients is essential in modulating the severity and pathophysiology of trypanosomosis and recovery (16). This is also in agreement with Akpa et al. (47), who reported the ability of diminazene aceturate to reverse the damages inflicted to the kidneys and liver in canine trypanosomosis. Pretreatment with resveratrol is beneficial in managing T. brucei infection, as it delays the onset of parasitemia and when combined with DA, it reverses damages done to the liver and kidneys. 

  • PDF (866 K)
  • XML
(2022). The beneficial effects of resveratrol supplementation on parasitemia, oxidative stress and serum biochemical parameters in Trypanosoma brucei infected dogs. Iraqi Journal of Veterinary Sciences, 36(3), 753-760. doi: 10.33899/ijvs.2022.131843.2009
Chigozie S Ukwueze; Polycarp O Akpa; Rita I Odo; Chinwe J Aronu; Boniface M Anene. "The beneficial effects of resveratrol supplementation on parasitemia, oxidative stress and serum biochemical parameters in Trypanosoma brucei infected dogs". Iraqi Journal of Veterinary Sciences, 36, 3, 2022, 753-760. doi: 10.33899/ijvs.2022.131843.2009
(2022). 'The beneficial effects of resveratrol supplementation on parasitemia, oxidative stress and serum biochemical parameters in Trypanosoma brucei infected dogs', Iraqi Journal of Veterinary Sciences, 36(3), pp. 753-760. doi: 10.33899/ijvs.2022.131843.2009
The beneficial effects of resveratrol supplementation on parasitemia, oxidative stress and serum biochemical parameters in Trypanosoma brucei infected dogs. Iraqi Journal of Veterinary Sciences, 2022; 36(3): 753-760. doi: 10.33899/ijvs.2022.131843.2009
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver

  1. Barrett MP, Burchmore RJS, Stich A, Lazzari JO, Frasch AC, Cazzulo JJ. The trypanosomiases. Lancet, 2003;362: 1469-1480
  2. Rashid A, Rasheed K, Hussain A. Trypanosomosis in a dog: A case report. Iran J Arthropod Borne Dis. 2008;2:48-51.
  3. Urquhart GM, Amour J, Duncan JL, Dunn AM, Jennings FW. Veterinary Parasitology 2nd Edition. Blackwell Science co. UK. 2002;PP.217
  4. Samdi SM, Abenga JN, Attahir A, Haruna MK, Wayo BM, Fajinmi AO, Sumayin HM, Usman AO, Hussaina JZ, Muhammad H, Yarnap JE, Ovbagbedia RP, Abudllah RA. Impact of trypanosomosis on food security. Security in Nigeria: A review. Int J Anim Vet Adv. 2010;2(2): 47-50.
  5. Swallow BM. Impacts of trypanosomosis in African Agriculture, Programme against African Trypanosomosis Technical and Scientific series, Food Agriculture Organization (FAO), 2000;2: 45 -46.
  6. Taiwo VO, Olaniyi MO, Ogunsanmi AO. Comparative plasma biochemical changes and susceptibility of erythrocytes to in vitro peroxidation during experimental Trypanosoma congolense and Trypanosoma brucei infection in sheep. Isr J Vet Med. 2003;58 (4), 435-443.
  7. Akanji MA, Adeyemi OS, Oguntoye F, Sulyman F. Psidium guajava extract reduces trypanosomosis associated lipid peroxidation and raises glutathione concentrations in infected animals. EXCLI J. 2009;8: 148-154.
  8. Gutteridge JMC. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem. 1995;41:1819-1828.
  9. Murray RK, Granner DK, Mayes PA, Rodwell VW. Harper’s Illustrated Biochemistry a Lange Medical Book, 26th ed. The McGraw-Hill Companies, Inc., United States of America. 2003;622-701.
  10. Barret MP, Bokykin DW, Brun R, Tidwell RR. Human African trypanosomosis: Pharmacological re-engagement with the neglected disease. Br J Pharmacol. 2007;152: 1155-1171.
  11. Anene BM, Onah DN, Nawa Y. Drug resistance in pathogenic African trypanosomes: what hopes for the future? Vet Parasitol.2001;96: 83-100.
  12. Eghianruwa KI, Oridupa OA. Chemotherapeutic control of trypanosomosis -a review of past measures, current status and future trends measures, current status and future trends. Vet Arh. 2018;88 (2): 245-270.
  13. Eghianruwa KI, Anika SM, Akpavie SO. Efficacy of diminazene with and without ascorbic acid supplementation in without ascorbic acid supplementation in T. brucei infected rats. Trop Vet. 2009;27, 20-36.
  14. Eghianruwa KI, Anika SM. The effects of selenium and tocopherol supplementation on efficacy of diminazene aceturate in reversing T. brucei-induced anaemia in rats. Vet Arh. 2011;81(5), 647-656.
  15. Eze JI, Ochike BO. Effects of dietary vitamin E supplementation on Trypanosoma brucei infected mice. Trop Vet. 2007;25(1), 18-25
  16. Eze JI, Ajanwachukwu N, Animoke PC, Onoja SO, Anosa GN, Eze UU. Immune Response, Anaemia and Oxidative Stress in Trypanosoma brucei Infected Rats Fed Vitamin E Supplemented Diet. Anti-Infective Agents. 2016;14(1):28-37
  17. Sinha K, Chaudhary, G, Gupta YK. Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci. 2002;71: 655-665.
  18. Baxter RA. Antiaging properties of resveratrol: Review and report of a potent new antioxidant skin care formulation. J Cosmet Dermatol. 2008;7, 2-7.
  19. NIH. Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington DC, USA 1996.
  20. Herbert WJ, Lumsden WH. Trypanosoma brucei: a rapid “matching” method for estimating the host’s parasitemia.Exp Parasitol. 1976;40: 427-431.
  21. Fauziah, PM., Maskoen AM, Yuliati, T, Widiarsih E. Optimized steps in determination of malondialdehyde (MDA) standards on diagnostic of lipid peroxidation. Padjajaran J Dent. 2018;30(2):136.
  22. Iwase, T, Tajima, A., Sugimoto, S, Okuda, K, Hironaka, I,Kamata, Y, Takada, K, Mizunoe, Y.A Simple Assay for Measuring Catalase Activity: A Visual Approach, Sci Rep. 2013;3:3081 .doi: 10.1038/srep03081.
  23. Hamad A, Elshahawy M, Negm A, Mansour F, 2019. Analytical methods for determination of glutathione and glutathione disulfide in pharmaceuticals and biological fluids. Rev Anal Chem. 2019;38(4) DOI: 10.1515/revac-2019-0019
  24. GaetaLM,  Tozzi G, Pastore A, federici, G, Bertini, E, Piemonte, F. Determination of superoxide dismutase and glutathione peroxidase activities in blood of healthy pediatric subjects. Clin Chim Acta. 2002;322(1-2):117-20.
  25. Kulkarni SS, Canto C. The molecular targets of resveratrol. Biochemical Biophysical. Acta Mol Basis Dis. 2015;1852 (6): 1114-1123.
  26. Singh CK, Ndiaye MA, Ahmad N. Reveratrol and cancer: Challenges for clinical translation. Biochim Biophys Acta Mol Basis Dis. 2015;1852 (6): 1178-1185
  27. Hughes DA. Effects of dietary antioxidants on the immune function of middle-aged adults. Proc Nutr Soc. 1999;58: 79-84.
  28. Umar IA, Toh ZA, Igbalajobi FI, A. Gidado A, Buratai LB. The role of vitamin C administration in alleviation of organ damage in rats infected with vitamin C administration in alleviation of organ damage in rats infected with Trypanosoma brucei brucei. J Clin Biochem. Nutr. 2000;28, 1-7.
  29. Eze JI, Anene BM, Chukwu CC. Determination of serum and organ malondialdehyde (MDA) concentration, a lipid peroxidation index, in Trypanosoma brucei infected rat.Comp Clin Path. 2008;17(2): 67-72.
  30. Kobo PI, J. Ayo JO, Aluwong T, Zezi AU, Maikai VA. Hematological Changes in Trypanosoma brucei brucei Infected Wistar Rats Treated with a Flavonoid Mixture and/or Diminazene Aceturate. Biol Med. 2014;6(213):1-6.
  31. Ihedioha JI, A. Anwa P. Lever retinal and carotenoid concentration of rats experimentally infected with experimentally infected with Trypanosoma brucei. Trop Vet. 2002 20: 1-7.
  32. Saleh MA, Al-Salahy MB, Sanousi SA. Oxidative stress in blood of camels (Camelus dromedaries) naturally infected with Trypanosoma evansi. Vet Parasitol. 2009;162:192-199.
  33. Dimri U, Sharma MC, Yamdagni A, Ranjan R, Zama MM. Psoroptic mange infestation increases oxidative stress and decreases antioxidant status in sheep. Vet Parasitol. 2010;168(3):318-22.
  34. Ranjithkumar M, Kamili NM, Saxena A, Dan A, S. Dey S, Raut SS. Disturbance of oxidant/antioxidant equilibrium in horses naturally infected with Trypanosoma evansi. Vet Parasitol. 2011;180(3):349-353.
  35. Adeyemi OS, Sulaiman FA. Biochemical and morphological changes in Trypanosoma brucei brucei infected rats treated with homidium chloride and diminazene aceturate. J Basic Clin Physiol Pharmacol. 2012;23(4):179-183.
  36. Takeet, MI, Fagbemi BO. Hematological, pathological and plasma biochemical changes in rabbits experimentally infected with Trypanosoma congolense. Sci. 2009;4(2)
  37. Yusuf AB, Umar IA, Nok AJ. Effects of methanol extract of Vernonia amygdalina leaf on survival and some biochemical parameters in acute Trypanosoma brucei brucei infection. Afr J Biomed Res. 2012;150-158.
  38. Hussain R, Khan A, Abbas RZ, Ghaffar A, Abbas G, Ali F. Clinico-Hematological and Biochemical Studies on Naturally Infected Camels with Trypanosomiasis.Pak J Zool. 2016;48(2).
  39. Awobode HO. The biochemical changes induced by natural human African trypanosome infections. Afr J Biotechnol. 2006;5:738-742.
  40. Abenga JN, Anosa VO. Serum total proteins and creatinine levels in experimental Gambian trypanosomosis of vervet monkeys. Afr J Biotechnol. 2005;(24):187-190.
  41. Abenga JN, Adamu S, Useh, NM, Nok, AJ, Ibrahim NDG, Sackey AKB, Esievo KAN. Renal and Hepatic Dysfunctions in Early Phase of Experimental Trypanosoma brucei Infection of Nigerian Pigs. Int J Biochem. Res. 2015;6(4): 178-188.
  42. Adejinmi JO, Akinboade OA. Serum biochemical changes in WAD goats with experimental mixed Trypanosoma brucei and Cowdria ruminantium infections. Trop Vet. 2000;18:111-120
  43. Orhue NEJ, Nwanze EAC, Okafor A. Serum total protein, albumin and globulin levels in T. brucei-infected rabbits: Effect of orally administered Scoparia dulcis. Afr J Biotechnol. 2005;4:1152-1155
  44. Allam, LD, Ogwu D, Agbede RIS, Sackey AKB. Hematological and serum biochemical changes in gilts experimentally infected with Trypanosoma brucei. Vet Arh. 2012;81(5):597-609.
  45. Sivajothi S, Rayulu VC, Sudhakara RB. Hematological and biochemical changes in experimental Trypanosoma evansi infection in rabbits. J Parasit Dis. 2015;39(2):216-220.
  46. Dagnachew S, Terefe G, Abebe G, Barry DJ, Goddeeris BM. Comparative biochemical changes in young Zebu cattle experimentally infected with Trypanosoma vivax from tsetse infested and non-tsetse infested areas of northwest Ethiopia. Vet. Parasitol. 2014;205(3):451-459.
  47. Akpa PO, Ezeokonkwo RC, Eze CA, Anene BM. Comparative efficacy assessment of Pentamidine isethionate and diminazene aceturate in the chemotherapy of Trypanosoma brucei brucei infection in dogs. Vet. Parasitol. 2008;151, 139-149.

  • Article View: 457
  • PDF Download: 185
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

© 2023, College of Veterinary Medicine, University of Mosul

 
This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus